The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma

Published:2016-06-20 Issue:12 Volume:57 Page:2763-2770
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Tomita Naoto,Suzuki Taisei,Miyashita Kazuho,Yamamoto Wataru,Motohashi Kenji,Tachibana Takayoshi,Takasaki Hirotaka,Kawasaki Rika,Hagihara Maki,Hashimoto Chizuko,Takemura Sachiya,Koharazawa Hideyuki,Yamazaki Etsuko,Taguchi Jun,Fujimaki Katsumichi,Fujita Hiroyuki,Sakai Rika,Fujisawa Shin,Motomura Shigeki,Kawamoto Keisuke,Sone Hirohito,Takizawa Jun

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428194.2016.1195498

Reference22 articles.

1. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

2. Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer?

3. Toxicity and response criteria of the Eastern Cooperative Oncology Group

4. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study;Blood Advances;2023-03-06

2. Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen;Future Science OA;2019-10-01

3. Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy;Annals of Hematology;2019-06-25

4. Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma;Leukemia & Lymphoma;2019-04-05

5. Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review;Critical Reviews in Oncology/Hematology;2019-01